Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
EVP, Chief Commercial Officer
-
Stock Symbol
-
CYTK on Nasdaq
There are no Buy or Sell transactions made by Andrew Callos since 9/17/2023
Holdings reported by Andrew Callos for Cytokinetics Inc
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
63.9K |
$4.27M |
$66.88 |
Mar 14, 2024 |
Direct |
|
|
| Non-Qualified Stock Option (Right to Buy) |
18.3K |
|
|
Mar 14, 2024 |
Direct |
Common Stock |
|
| Incentive Stock Option (Right to Buy) |
1.22K |
|
|
Mar 14, 2024 |
Direct |
Common Stock |
|
Transactions reported by Andrew Callos for Cytokinetics Inc
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.